KPV Peptide Product Description
KPV (Lys–Pro–Val) is the C-terminal tripeptide fragment of α-melanocyte stimulating hormone (α-MSH). As a small, bioactive peptide, KPV reproduces many of α-MSH’s anti-inflammatory, antimicrobial and tissue-protective activities while avoiding full-length melanocortin receptor signaling in some contexts.
In research settings, KPV has been studied for:
- Potent anti-inflammatory action — suppresses pro-inflammatory cytokines and leukocyte activation
- Antimicrobial activity — direct candidacidal and bactericidal effects reported for α-MSH C-terminal fragments including KPV
- Mucosal and epithelial protection / wound healing — accelerates epithelial repair in corneal and other epithelial models
- Anti-fibrotic and immunomodulatory effects — reduces fibrosis and shifts macrophage phenotypes in preclinical studies
The KPV peptide sequence is a useful research tool for studying innate immune regulation, mucosal defense and novel anti-inflammatory peptide mechanisms.
Product Specifications
| Property | Value |
|---|---|
| Peptide Sequence | Lys-Pro-Val (H-Lys-Pro-Val-OH) |
| Molecular Formula | C16H30N4O4 |
| Molecular Weight | 342.43 g/mol |
| CAS Number | 67727-97-3 |
| PubChem CID | 125672 |
| Synonyms | α-MSH(11-13), ACTH(11-13), MSH(11-13) |
Lyophilized Peptides:
These peptides are freeze-dried, a process that not only extends shelf life but also preserves the purity and integrity of the peptides during storage. We do not use any fillers in this process.
